Literature DB >> 12793793

Syphilis and human immunodeficiency virus co-infection.

Allen S Funnyé1, Abbasi J Akhtar.   

Abstract

Co-infection of syphilis and AIDS has profound implications for the African American community. The purpose of this review is to: evaluate the historical background of HIV and syphilis and their similarities in pathogenesis; review the epidemiology of syphilis and HIV co-infection, and implications for continued prevention efforts; examine the effect of syphilis on HIV transmission and acquisition; and, to examine the effects of HIV infection on syphilis transmission, diagnostic and serologic changes, clinical course, and treatment. The prevalence of HIV is higher in those with syphilis; moreover, the prevalence of HIV and syphilis co-infection is highest in African Americans. There may be humoral and cellular immune similarities. HIV may affect the transmission of syphilis, alter its serologic diagnosis, and accelerate and change the clinical course and response to treatment. In conclusion, combined infection of HIV and syphilis may alter the clinical presentation and course of either disease. There are historical and immunologic similarities and the high prevalence in African Americans compared to other groups is of great importance for prevention efforts.

Entities:  

Mesh:

Year:  2003        PMID: 12793793      PMCID: PMC2594513     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  87 in total

1.  Fracastoro and syphilis: 500 years on.

Authors:  M M Hudson; R S Morton
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

2.  Unusual manifestations of syphilis with human immunodeficiency virus infection.

Authors:  W E McDaniel
Journal:  J Am Acad Dermatol       Date:  1988-09       Impact factor: 11.527

3.  Recommendations for diagnosing and treating syphilis in HIV-infected patients.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-10-07       Impact factor: 17.586

Review 4.  The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria.

Authors:  M C Dickerson; J Johnston; T E Delea; A White; E Andrews
Journal:  Sex Transm Dis       Date:  1996 Sep-Oct       Impact factor: 2.830

5.  Time to hit HIV, early and hard.

Authors:  D D Ho
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

6.  Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis.

Authors:  P G van der Valk; E J Kraai; P C van Voorst Vader; H Haaxma-Reiche; J A Snijder
Journal:  Genitourin Med       Date:  1988-08

7.  Serologic response to treatment of syphilis in patients with HIV infection.

Authors:  A M Yinnon; P Coury-Doniger; R Polito; R C Reichman
Journal:  Arch Intern Med       Date:  1996-02-12

Review 8.  [Acquired syphilis and HIV infection].

Authors:  R Laurent
Journal:  Presse Med       Date:  1994-11-12       Impact factor: 1.228

9.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

Authors:  H Grosskurth; F Mosha; J Todd; E Mwijarubi; A Klokke; K Senkoro; P Mayaud; J Changalucha; A Nicoll; G ka-Gina
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

10.  Biological false-positive syphilis test results for women infected with human immunodeficiency virus.

Authors:  M H Augenbraun; J A DeHovitz; J Feldman; L Clarke; S Landesman; H M Minkoff
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more
  9 in total

1.  Evaluation of the Treponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis.

Authors:  Rita Castro; Emília S Prieto; Maria João Aguas; Maria José Manata; Júlio Botas; Carlos Araújo; Fernando Borges; Isabel Aldir; Filomena da L Exposto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Syphilis and HIV Co-infection in Mississippi: Implications for Control and Prevention.

Authors:  Lee T Riley; Kendra L Johnson; James Stewart; Paul Byers
Journal:  AIDS Behav       Date:  2020-04

3.  Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.

Authors:  Sergio Monteiro de Almeida; Archana Bhatt; Patricia K Riggs; Janis Durelle; Deborah Lazzaretto; Jennifer Marquie-Beck; Allen McCutchan; Scott Letendre; Ronald Ellis
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

4.  Jaundice in African-American and Hispanic patients with AIDS.

Authors:  Abbasi J Akhtar; Magda Shaheen
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

5.  Frequency of human immunodeficiency virus infection among students of tertiary and secondary institutions in an endemic state.

Authors:  Abdulazeez Abubakar
Journal:  N Am J Med Sci       Date:  2012-04

6.  Distribution of CD4 Lymphocyte Cells Among Apparently Healthy HIV Seropositive and Seronegative Populations.

Authors:  Abdulazeez A Abubakar
Journal:  N Am J Med Sci       Date:  2012-03

7.  Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.

Authors:  Ratish Gambhira; Brandon F Keele; John B Schell; Meredith J Hunter; Jason P Dufour; David C Montefiori; Haili Tang; John K Rose; Nina Rose; Preston A Marx
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

8.  Prevalence of syphilis, neurosyphilis and associated factors in a cross-sectional analysis of HIV infected patients attending Bugando Medical Centre, Mwanza, Tanzania.

Authors:  Adeodatus Haule; Betrand Msemwa; Evarista Mgaya; Peter Masikini; Samuel Kalluvya
Journal:  BMC Public Health       Date:  2020-12-04       Impact factor: 3.295

9.  Factors associated with syphilis treatment failure and reinfection: a longitudinal cohort study in Shenzhen, China.

Authors:  Zhenzhou Luo; Lin Zhu; Yi Ding; Jun Yuan; Wu Li; Qiuhong Wu; Lishan Tian; Li Zhang; Guomao Zhou; Tao Zhang; Jianping Ma; Zhongwei Chen; Tubao Yang; Tiejian Feng; Min Zhang
Journal:  BMC Infect Dis       Date:  2017-09-13       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.